Shi Hubing
Shi Hubing
UCLA
Verified email at scu.edu.cn
Title
Cited by
Cited by
Year
Melanomas acquire resistance to B-RAF (V600E) inhibition by RTK or N-RAS upregulation
R Nazarian, H Shi, Q Wang, X Kong, RC Koya, H Lee, Z Chen, MK Lee, ...
Nature 468 (7326), 973-977, 2010
20992010
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF (V600E)
PI Poulikakos, Y Persaud, M Janakiraman, X Kong, C Ng, G Moriceau, ...
Nature 480 (7377), 387-390, 2011
12872011
Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy
H Shi, W Hugo, X Kong, A Hong, RC Koya, G Moriceau, T Chodon, R Guo, ...
Cancer discovery 4 (1), 80-93, 2014
7422014
Melanoma whole-exome sequencing identifies V600E B-RAF amplification-mediated acquired B-RAF inhibitor resistance
H Shi, G Moriceau, X Kong, MK Lee, H Lee, RC Koya, C Ng, T Chodon, ...
Nature communications 3 (1), 1-8, 2012
6302012
Non-genomic and immune evolution of melanoma acquiring MAPKi resistance
W Hugo, H Shi, L Sun, M Piva, C Song, X Kong, G Moriceau, A Hong, ...
Cell 162 (6), 1271-1285, 2015
3662015
Therapy-induced tumour secretomes promote resistance and tumour progression
AC Obenauf, Y Zou, AL Ji, S Vanharanta, W Shu, H Shi, X Kong, ...
Nature 520 (7547), 368-372, 2015
3282015
MDM4 is a key therapeutic target in cutaneous melanoma
A Gembarska, F Luciani, C Fedele, EA Russell, M Dewaele, S Villar, ...
Nature medicine 18 (8), 1239-1247, 2012
2782012
Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin
H Shi, Y Huang, H Zhou, X Song, S Yuan, Y Fu, Y Luo
Blood 110 (8), 2899-2906, 2007
2712007
Combinatorial treatments that overcome PDGFRβ-driven resistance of melanoma cells to V600EB-RAF inhibition
H Shi, X Kong, A Ribas, RS Lo
Cancer research 71 (15), 5067-5074, 2011
2272011
Tunable-combinatorial mechanisms of acquired resistance limit the efficacy of BRAF/MEK cotargeting but result in melanoma drug addiction
G Moriceau, W Hugo, A Hong, H Shi, X Kong, CY Clarissa, RC Koya, ...
Cancer cell 27 (2), 240-256, 2015
2252015
The regulatory mechanism of Hsp90α secretion and its function in tumor malignancy
X Wang, X Song, W Zhuo, Y Fu, H Shi, Y Liang, M Tong, G Chang, Y Luo
Proceedings of the National Academy of Sciences 106 (50), 21288-21293, 2009
2052009
The angiogenic function of nucleolin is mediated by vascular endothelial growth factor and nonmuscle myosin
Y Huang, H Shi, H Zhou, X Song, S Yuan, Y Luo
Blood 107 (9), 3564-3571, 2006
1942006
Pulmonary vascular destabilization in the premetastatic phase facilitates lung metastasis
Y Huang, N Song, Y Ding, S Yuan, X Li, H Cai, H Shi, Y Luo
Cancer research 69 (19), 7529-7537, 2009
1832009
Voltage‐dependent anion channel 1 is involved in endostatin‐induced endothelial cell apoptosis
S Yuan, Y Fu, X Wang, H Shi, Y Huang, X Song, L Li, N Song, Y Luo
The FASEB Journal 22 (8), 2809-2820, 2008
1602008
A novel AKT1 mutant amplifies an adaptive melanoma response to BRAF inhibition
H Shi, A Hong, X Kong, RC Koya, C Song, G Moriceau, W Hugo, ...
Cancer discovery 4 (1), 69-79, 2014
1482014
Overexpression of platelet-derived growth factor-BB increases tumor pericyte content via stromal-derived factor-1α/CXCR4 axis
N Song, Y Huang, H Shi, S Yuan, Y Ding, X Song, Y Fu, Y Luo
Cancer research 69 (15), 6057-6064, 2009
1212009
The regulatory mechanism of extracellular Hsp90α on matrix metalloproteinase-2 processing and tumor angiogenesis
X Song, X Wang, W Zhuo, H Shi, D Feng, Y Sun, Y Liang, Y Fu, D Zhou, ...
Journal of Biological Chemistry 285 (51), 40039-40049, 2010
992010
Preexisting MEK1 exon 3 mutations in V600E/KBRAF melanomas do not confer resistance to BRAF inhibitors
H Shi, G Moriceau, X Kong, RC Koya, R Nazarian, GM Pupo, ...
Cancer discovery 2 (5), 414-424, 2012
972012
Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy. Cancer Discov. 2014; 4: 80–93. doi: 10.1158/2159-8290
H Shi, W Hugo, X Kong, A Hong, RC Koya, G Moriceau, T Chodon, R Guo, ...
CD-13-0642.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0
63
Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours
H Yao, J Lan, C Li, H Shi, JP Brosseau, H Wang, H Lu, C Fang, Y Zhang, ...
Nature Biomedical Engineering 3 (4), 306-317, 2019
502019
The system can't perform the operation now. Try again later.
Articles 1–20